Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • DanFrost
    Member
    • Dec 2011
    • 21

    #1

    Hello from Bozeman, Montana

    Hello everyone, I am a long time lurker here at SEQanswers but finally registered to participate in the community more actively. My name is Dan, my background is in statistics, and I work for a commercial bioinformatics software and service group called Golden Helix.

    Again, just thought I would say hello!
  • turnersd
    Senior Member
    • May 2011
    • 115

    #2
    Hello Dan, Welcome.

    Stephen (UVA Bioinformatics Core)

    Comment

    • DanFrost
      Member
      • Dec 2011
      • 21

      #3
      Thanks Stephen, I'm glad to be here!

      Comment

      • astat
        Junior Member
        • Jan 2012
        • 3

        #4
        Hi! I'm also in MT (Missoula) and just signed up here. Just beginning to step into the bioinformatics myself. I'm a grad student at UM...hoping to make use of sequencing technologies in the not too distant future!

        Comment

        • DanFrost
          Member
          • Dec 2011
          • 21

          #5
          astat - Are you in your first year of their program? We should connect for sure. I'd be happy to be a local resource.

          Comment

          • jflowers
            Member
            • Oct 2011
            • 42

            #6
            Hi astat, this is Jonathan from NYC, your id looks familiar Welcome to seqanswers!

            Comment

            • astat
              Junior Member
              • Jan 2012
              • 3

              #7
              Hi Dan - I'm in my third year already, so lots of catching up to do! Mostly figuring out what I might need to sequence in the next few months, and what I can do with existing data.


              Jonathan! Good to hear from you! I figure it's time for me to start spending some serious time with this bioinformatics business.

              Comment

              • DanFrost
                Member
                • Dec 2011
                • 21

                #8
                Thanks for the heads up astat - I will PM you with a few other inquiries.

                Cheers.

                Comment

                Latest Articles

                Collapse

                • SEQadmin2
                  Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
                  by SEQadmin2



                  CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

                  Despite this, “CRISPR helped turn genome editing from a specialized technique into
                  ...
                  07-31-2026, 11:01 AM
                • SEQadmin2
                  Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                  by SEQadmin2


                  Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                  The systematic characterization of the human proteome has
                  ...
                  07-20-2026, 11:48 AM
                • SEQadmin2
                  Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                  by SEQadmin2



                  Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                  ...
                  07-09-2026, 11:10 AM

                ad_right_rmr

                Collapse

                News

                Collapse

                Topics Statistics Last Post
                Started by SEQadmin2, 07-31-2026, 02:55 AM
                0 responses
                18 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-24-2026, 12:17 PM
                0 responses
                15 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-23-2026, 11:41 AM
                0 responses
                14 views
                0 reactions
                Last Post SEQadmin2  
                Started by SEQadmin2, 07-20-2026, 11:10 AM
                0 responses
                25 views
                0 reactions
                Last Post SEQadmin2  
                Working...